NCT03671044 2025-03-21
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
Jina Pharmaceuticals Inc.
Phase 3 Recruiting
Clinical Trials
3 trialsNCT01216111 2020-05-19
Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)
Fudan University
Phase 3 Completed
NCT01642771 2017-04-19
Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer
China Breast Cancer Clinical Study Group
Phase 3 Unknown